Media invitation: 4th International Conference on Teenage and Young Adult Cancer Medicine

December 07, 2005

You are invited to attend the world's only conference on cancer and the adolescent. Organised by Teenage Cancer Trust, the two-day conference will see leading specialists from around the world present new research findings to the conference on incidence, possible causes for adolescent cancer, treatment and survival (including the dearth of clinical trials for this age group), effects on future fertility, and problems of compliance with treatment.

They will discuss difficult or controversial topics such as routine vaccination against HPV for girls, whether or not health insurance in countries that do not have a free national health service actually buys better treatment for young people, and why it is that more teenagers and young adults are developing cancer now than ever before.

Teenage Cancer Trust (TCT) is a pioneering UK charity that was established to focus on the most neglected group of cancer patients - teenagers and young adults. As a result of the Trust's work, the UK is the only country in the world to have a programme of developing specialist units for adolescents. Currently, there are seven TCT units, but a further 15 are needed to ensure that every adolescent with cancer in the UK has access to one. TCT expects a 15% increase in survival rates as a result of the concentration of expertise within the units. Other countries are now beginning to follow the UK's lead.

Registration is free for bona fide UK and international media. You are welcome to attend all conference sessions on the 30 and 31 March. There will be a news briefing for the media at 10.30am on Wednesday 29 March with key speakers and patients at the Royal College of Physicians.
-end-
A media conference registration form and conference programme is available from:
TCT media consultant, Emma Mason: Tel: 44-137-656-3090
Email: wordmason@mac.com

Or (if Emma is unavailable):
Lucy Jackson at Teenage Cancer Trust: Tel: 44-207-529-8608
Email: lucy@teenagecancertrust.org

Early media registration is strongly recommended, as places at the conference are limited.

For more information on the Trust, visit www.teenagecancertrust.org

Teenage Cancer Trust

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.